A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
Clinical trial NCT00951275 · COMPLETED
Trial details
- NCT number
- NCT00951275
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-31
- Primary completion
- 2011-07-22
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.